Patents Assigned to Zomanex, LLC

Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs

Patent number: 9107825

Abstract: A hydrophobic drug delivery system that includes a plant derived sterol (stanol) or a sterol (stanol) derived ester, an emulsifier and an active, hydrophobic drug, all dissolved and then dried to form a liposome delivery system.

Type: Grant

Filed: December 17, 2012

Date of Patent: August 18, 2015

Assignee: ZOMANEX, LLC

Inventor: Curtis A. Spilburg
METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND GASTRO-INTESTINAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS

Publication number: 20130108689

Abstract: A hydrophobic drug delivery system that includes a plant derived sterol (stanol) or a sterol (stanol) derived ester, an emulsifier and an active, hydrophobic drug, all dissolved and then dried to form a liposome delivery system.

Type: Application

Filed: December 17, 2012

Publication date: May 2, 2013

Applicant: ZOMANEX, LLC

Inventor: Zomanex, LLC
METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS

Publication number: 20110111009

Abstract: A method of preparing and composition of bioavailable hydrophobic, poorly water soluble drugs. It uses for example, lecithin, sterol, a calcium salt, and solvent; mixing to form liposomes and then the solvent driven off; the ratios used and physical form differ from others, and maximize performance.

Type: Application

Filed: January 20, 2011

Publication date: May 12, 2011

Applicant: ZOMANEX LLC

Inventor: CURTIS A. SPILBURG
METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS

Publication number: 20090088393

Abstract: Oral dosage compositions for drugs normally given intravenously such as Paclitaxel, containing a plant sterol to enhance solubility and a small intestine efflux inhibitor to prevent P-glycoprotein from being a barrier to absorption.

Type: Application

Filed: September 28, 2007

Publication date: April 2, 2009

Applicant: ZOMANEX, LLC

Inventor: CURTIS A. SPILBURG
Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone

Publication number: 20050153948

Abstract: The present invention describes a composition that contains a plant sterol or plant stanol or their fatty acid esters and an emulsifier for treating conditions that are related to elevated dihydrotestosterone. The compositions can be prepared in a dry form for use as a food ingredient, tablet or capsule. Alternatively, the compositions can be dissolved in oil.

Type: Application

Filed: November 15, 2004

Publication date: July 14, 2005

Applicant: Zomanex, LLC

Inventor: Curtis Spilburg

Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs

METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND GASTRO-INTESTINAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS

METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS

METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS

Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone